State Street Corp Revolution Medicines, Inc. Transaction History

State Street Corp

$2.36 Trillion
Q1 2025

A detailed history of State Street Corp transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, State Street Corp holds 5,804,919 shares of RVMD stock, worth $222 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

5,804,919

Previous 5,791,752 0.23%

Holding current value

$222 Million

Previous $253 Million 18.98%

% of portfolio

0.01%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$35.36 - $44.42 $465,585 - $584,878	13,167 Added 0.23%	5,804,919 $205 Million
Q4 2024 Feb 14, 2025	BUY	$42.97 - $60.6 $22 Million - $31 Million	512,168 Added 9.7%	5,791,752 $253 Million
Q3 2024 Nov 14, 2024	BUY	$36.92 - $47.94 $7.7 Million - $10 Million	208,516 Added 4.11%	5,279,584 $239 Million
Q2 2024 Aug 14, 2024	SELL	$30.14 - $40.68 $9.49 Million - $12.8 Million	-314,952 Reduced 5.85%	5,071,068 $197 Million
Q1 2024 May 15, 2024	SELL	$26.56 - $33.55 $23 Million - $29.1 Million	-867,341 Reduced 13.87%	5,386,020 $174 Million
Q4 2023 Feb 14, 2024	BUY	$18.35 - $34.12 $43.8 Million - $81.4 Million	2,385,751 Added 61.69%	6,253,361 $179 Million
Q3 2023 Nov 14, 2023	SELL	$25.17 - $35.05 $22.1 Million - $30.7 Million	-876,639 Reduced 18.48%	3,867,610 $107 Million
Q2 2023 Aug 14, 2023	SELL	$20.28 - $27.0 $1.36 Million - $1.81 Million	-67,182 Reduced 1.4%	4,744,249 $127 Million
Q1 2023 May 15, 2023	BUY	$20.76 - $30.09 $21.4 Million - $31 Million	1,030,420 Added 27.25%	4,811,431 $104 Million
Q4 2022 Feb 14, 2023	SELL	$17.68 - $25.53 $9.39 Million - $13.6 Million	-531,123 Reduced 12.32%	3,781,011 $90.1 Million
Q3 2022 Nov 15, 2022	BUY	$17.46 - $26.0 $21.3 Million - $31.6 Million	1,217,152 Added 39.33%	4,312,134 $85 Million
Q2 2022 Aug 15, 2022	BUY	$14.54 - $27.17 $3.66 Million - $6.83 Million	251,505 Added 8.84%	3,094,982 $60.3 Million
Q1 2022 May 16, 2022	BUY	$17.31 - $26.4 $1.54 Million - $2.35 Million	88,844 Added 3.23%	2,843,477 $72.5 Million
Q4 2021 Feb 14, 2022	SELL	$24.35 - $33.7 $1.33 Million - $1.84 Million	-54,539 Reduced 1.94%	2,754,633 $69.3 Million
Q3 2021 Nov 15, 2021	BUY	$23.95 - $33.41 $11 Million - $15.4 Million	460,582 Added 19.61%	2,809,172 $77.3 Million
Q2 2021 Aug 16, 2021	BUY	$29.0 - $47.44 $16.5 Million - $27.1 Million	570,410 Added 32.08%	2,348,590 $74.5 Million
Q1 2021 May 17, 2021	SELL	$37.21 - $54.43 $481,943 - $704,977	-12,952 Reduced 0.72%	1,778,180 $81.6 Million
Q4 2020 Feb 16, 2021	BUY	$30.19 - $45.49 $21.7 Million - $32.8 Million	720,230 Added 67.25%	1,791,132 $70.9 Million
Q3 2020 Nov 10, 2020	BUY	$22.61 - $34.8 $18.3 Million - $28.1 Million	808,613 Added 308.29%	1,070,902 $37.3 Million
Q2 2020 Aug 14, 2020	BUY	$19.65 - $39.34 $507,716 - $1.02 Million	25,838 Added 10.93%	262,289 $8.28 Million
Q1 2020 May 11, 2020	BUY	$20.0 - $34.08 $4.73 Million - $8.06 Million	236,451 New	236,451 $5.18 Million

Others Institutions Holding RVMD

# of Institutions

306

Shares Held

189M

Call Options Held

186K

Put Options Held

672K

View Full List

About Revolution Medicines, Inc.

Ticker RVMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,697,600
Market Cap $3.36B
Description
Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...

More about RVMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Revolution Medicines, Inc. Transaction History